35750-91-5

Upstream product

• 540-37-4 p-aminoiodobenzene 
• 5470-18-8 2-Chloro-3-nitropyridine 
• 35750-90-4 4-(N-phenylamino)-3-nitropyridine 
• 62-53-3 aniline 
• 35826-31-4 3-amino-4-(phenylamino)pyridine 
• 149-73-5 trimethyl orthoformate 
• 64-19-7 acetic acid 
• 13091-23-1 4-chloro-3-nitropyridine 
• 103-84-4 Acetanilid 
• 167694-20-4 (4-Iodo-phenyl)-(3-nitro-pyridin-4-yl)-amine 
• 167694-21-5 3-amino-4-(4-iodophenyl)aminopyridine 

Downstream Products

• 1078168-17-8 C₁₃H₁₁N₃O 

Relevant academic research and scientific papers

P2X7 MODULATORS

The present invention is directed to compounds of Formulas (I, IIa and IIb): The invention also relates to pharmaceutical compositions comprising compounds of Formulas (I, IIa and IIb). Methods of making and using the compounds of Formulas (I, IIa and IIb) are also within the scope of the invention.

A direct, regioselective palladium-catalyzed synthesis of N-substituted benzimidazoles and imidazopyridines

Unsymmetric, N-substituted benzimidazoles and imidazopyridines can be prepared directly from 2-halonitroarenes and amides through Pd(TFA) 2/(R)-BINAP-catalyzed cross-coupling and subsequent reductive aminocyclization. This sequence can be conducted by a one-pot procedure. The method is versatile and allows the straightforward, regioselective preparation of these important nitrogen heterocycles. Unsymmetrical, N-substituted benzimidazoles can be prepared directly from 2-halonitroarenes and amides through Pd(TFA)2/(R)-BINAP-catalyzed cross-coupling and subsequent reductive aminocyclization.This sequence can be conducted by a one-pot procedure. The method is versatile and allows the straightforward, regioselective preparation of these important nitrogen heterocycles. Copyright

Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors

We report the structure-based design and synthesis of a novel series of aza-benzimidazoles as PHD2 inhibitors. These efforts resulted in compound 22, which displayed highly potent inhibition of PHD2 function in vitro.

A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles

The present invention relates to a process for the regioselective synthesis of compounds of the formula I, wherein R0; R1; R2; R3; R4; R5; A1; A2; A3; A4, Q and J have the meanings indicated in the claims. The present invention provides a direct palladium catalyzed, regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted amides useful for the production of pharmaceuticals, diagnostic agents, liquid crystals, polymers, herbicides, fungicidals, nematicidals, parasiticides, insecticides, acaricitdes and arthropodicides.

Novel Antagonists of Platelet-Activating Factor. 1. Synthesis and Structure-Activity Relationships of Benzodiazepine and Benzazepine Derivatives of 2-Methyl-1-phenylimidazopyridine

Following the discovery of moderately potent antagonist activity against platelet-activating factor (PAF) in 2-methyl-1-phenylimidazopyridine (2) (IC50=840 nM), 19 derivatives (3-21) were prepared which incorporated various lipophilic groups attach